Andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the NRF2 signaling pathway

Abstract Background Bone marrow mesenchymal stem cell (BMSCs) therapy is an important cell transplantation strategy in the regenerative medicine field. However, a severely ischemic microenvironment, such as nutrient depletion and hypoxia, causes a lower survival rate of transplanted BMSCs, limiting...

Full description

Bibliographic Details
Main Authors: Yanting Sun, Hao Xu, Bin Tan, Qin Yi, Huiwen Liu, Tangtian Chen, Han Xiang, Rui Wang, Qiumin Xie, Jie Tian, Jing Zhu
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-022-03016-6
_version_ 1811287336925790208
author Yanting Sun
Hao Xu
Bin Tan
Qin Yi
Huiwen Liu
Tangtian Chen
Han Xiang
Rui Wang
Qiumin Xie
Jie Tian
Jing Zhu
author_facet Yanting Sun
Hao Xu
Bin Tan
Qin Yi
Huiwen Liu
Tangtian Chen
Han Xiang
Rui Wang
Qiumin Xie
Jie Tian
Jing Zhu
author_sort Yanting Sun
collection DOAJ
description Abstract Background Bone marrow mesenchymal stem cell (BMSCs) therapy is an important cell transplantation strategy in the regenerative medicine field. However, a severely ischemic microenvironment, such as nutrient depletion and hypoxia, causes a lower survival rate of transplanted BMSCs, limiting the application of BMSCs. Therefore, improving BMSCs viability in adverse microenvironments is an important means to improve the effectiveness of BMSCs therapy. Objective To illustrate the protective effect of andrographolide (AG) against glucose and serum deprivation under hypoxia (1% O2) (GSDH)-induced cell injury in BMSCs and investigate the possible underlying mechanisms. Methods An in vitro primary rat BMSCs cell injury model was established by GSDH, and cellular viability, proliferation and apoptosis were observed after AG treatment under GSDH. Reactive oxygen species levels and oxidative stress-related genes and proteins were measured by flow cytometry, RT-qPCR and Western blotting. Mitochondrial morphology, function and number were further assessed by laser confocal microscopy and flow cytometry. Results AG protected BMSCs against GSDH-induced cell injury, as indicated by increases in cell viability and proliferation and mitochondrial number and decreases in apoptosis and oxidative stress. The metabolic status of BMSCs was changed from glycolysis to oxidative phosphorylation to increase the ATP supply. We further observed that the NRF2 pathway was activated by AG, and treatment of BMSCs with a specific NRF2 inhibitor (ML385) blocked the protective effect of AG. Conclusion Our results suggest that AG is a promising agent to improve the therapeutic effect of BMSCs.
first_indexed 2024-04-13T03:15:36Z
format Article
id doaj.art-c0df81f62dbe46098b0579ed67d91368
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-04-13T03:15:36Z
publishDate 2022-07-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-c0df81f62dbe46098b0579ed67d913682022-12-22T03:04:55ZengBMCStem Cell Research & Therapy1757-65122022-07-0113111810.1186/s13287-022-03016-6Andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the NRF2 signaling pathwayYanting Sun0Hao Xu1Bin Tan2Qin Yi3Huiwen Liu4Tangtian Chen5Han Xiang6Rui Wang7Qiumin Xie8Jie Tian9Jing Zhu10Department of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of PediatricsAbstract Background Bone marrow mesenchymal stem cell (BMSCs) therapy is an important cell transplantation strategy in the regenerative medicine field. However, a severely ischemic microenvironment, such as nutrient depletion and hypoxia, causes a lower survival rate of transplanted BMSCs, limiting the application of BMSCs. Therefore, improving BMSCs viability in adverse microenvironments is an important means to improve the effectiveness of BMSCs therapy. Objective To illustrate the protective effect of andrographolide (AG) against glucose and serum deprivation under hypoxia (1% O2) (GSDH)-induced cell injury in BMSCs and investigate the possible underlying mechanisms. Methods An in vitro primary rat BMSCs cell injury model was established by GSDH, and cellular viability, proliferation and apoptosis were observed after AG treatment under GSDH. Reactive oxygen species levels and oxidative stress-related genes and proteins were measured by flow cytometry, RT-qPCR and Western blotting. Mitochondrial morphology, function and number were further assessed by laser confocal microscopy and flow cytometry. Results AG protected BMSCs against GSDH-induced cell injury, as indicated by increases in cell viability and proliferation and mitochondrial number and decreases in apoptosis and oxidative stress. The metabolic status of BMSCs was changed from glycolysis to oxidative phosphorylation to increase the ATP supply. We further observed that the NRF2 pathway was activated by AG, and treatment of BMSCs with a specific NRF2 inhibitor (ML385) blocked the protective effect of AG. Conclusion Our results suggest that AG is a promising agent to improve the therapeutic effect of BMSCs.https://doi.org/10.1186/s13287-022-03016-6BMSCsNRF2AndrographolideApoptosisOxidative stress
spellingShingle Yanting Sun
Hao Xu
Bin Tan
Qin Yi
Huiwen Liu
Tangtian Chen
Han Xiang
Rui Wang
Qiumin Xie
Jie Tian
Jing Zhu
Andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the NRF2 signaling pathway
Stem Cell Research & Therapy
BMSCs
NRF2
Andrographolide
Apoptosis
Oxidative stress
title Andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the NRF2 signaling pathway
title_full Andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the NRF2 signaling pathway
title_fullStr Andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the NRF2 signaling pathway
title_full_unstemmed Andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the NRF2 signaling pathway
title_short Andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the NRF2 signaling pathway
title_sort andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the nrf2 signaling pathway
topic BMSCs
NRF2
Andrographolide
Apoptosis
Oxidative stress
url https://doi.org/10.1186/s13287-022-03016-6
work_keys_str_mv AT yantingsun andrographolideprotectsbonemarrowmesenchymalstemcellsagainstglucoseandserumdeprivationunderhypoxiaviathenrf2signalingpathway
AT haoxu andrographolideprotectsbonemarrowmesenchymalstemcellsagainstglucoseandserumdeprivationunderhypoxiaviathenrf2signalingpathway
AT bintan andrographolideprotectsbonemarrowmesenchymalstemcellsagainstglucoseandserumdeprivationunderhypoxiaviathenrf2signalingpathway
AT qinyi andrographolideprotectsbonemarrowmesenchymalstemcellsagainstglucoseandserumdeprivationunderhypoxiaviathenrf2signalingpathway
AT huiwenliu andrographolideprotectsbonemarrowmesenchymalstemcellsagainstglucoseandserumdeprivationunderhypoxiaviathenrf2signalingpathway
AT tangtianchen andrographolideprotectsbonemarrowmesenchymalstemcellsagainstglucoseandserumdeprivationunderhypoxiaviathenrf2signalingpathway
AT hanxiang andrographolideprotectsbonemarrowmesenchymalstemcellsagainstglucoseandserumdeprivationunderhypoxiaviathenrf2signalingpathway
AT ruiwang andrographolideprotectsbonemarrowmesenchymalstemcellsagainstglucoseandserumdeprivationunderhypoxiaviathenrf2signalingpathway
AT qiuminxie andrographolideprotectsbonemarrowmesenchymalstemcellsagainstglucoseandserumdeprivationunderhypoxiaviathenrf2signalingpathway
AT jietian andrographolideprotectsbonemarrowmesenchymalstemcellsagainstglucoseandserumdeprivationunderhypoxiaviathenrf2signalingpathway
AT jingzhu andrographolideprotectsbonemarrowmesenchymalstemcellsagainstglucoseandserumdeprivationunderhypoxiaviathenrf2signalingpathway